The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human phase 1-2A study of CB-103, an oral Protein-Protein Interaction Inhibitor targeting pan-NOTCH signalling in advanced solid tumors and blood malignancies.
 
Jose Manuel Perez Garcia
No Relationships to Disclose
 
Javier Cortés
Honoraria - Celgene; Eisai; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Biothera; Celgene; Cellestia Biotech; Merus; Roche
 
Anastasios Stathis
No Relationships to Disclose
 
Rogier Mous
No Relationships to Disclose
 
Elena López-Miranda
No Relationships to Disclose
 
Analía Azaro
No Relationships to Disclose
 
Sofia Genta
No Relationships to Disclose
 
Paolo Nuciforo
No Relationships to Disclose
 
Ana Vivancos
No Relationships to Disclose
 
Renata Ferrarotto
Consulting or Advisory Role - Ayala Pharmaceuticals
Research Funding - AstraZeneca/MedImmune (Inst); EMD Serono (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); Merck Serono (Inst); OncoMed (Inst)
 
Francesco Bertoni
No Relationships to Disclose
 
Davide Rossi
No Relationships to Disclose
 
Nicole Spardy Burr
No Relationships to Disclose
 
Oliver Schönborn-Kellenberger
Consulting or Advisory Role - Cellestia Biotech
 
Karin Jorga
Consulting or Advisory Role - Cellestia Biotech
 
Laura Beni
Employment - Cellestia Biotech
 
Rajwinder Lehal
Employment - Cellestia Biotech
 
Michael Bauer
Employment - Cellestia Biotech
 
Dirk Weber
Employment - Cellestia Biotech
 
Elena Garralda
Consulting or Advisory Role - Roche